KR100272483B1 - 지질 대사 개선제 - Google Patents

지질 대사 개선제 Download PDF

Info

Publication number
KR100272483B1
KR100272483B1 KR1019940006835A KR19940006835A KR100272483B1 KR 100272483 B1 KR100272483 B1 KR 100272483B1 KR 1019940006835 A KR1019940006835 A KR 1019940006835A KR 19940006835 A KR19940006835 A KR 19940006835A KR 100272483 B1 KR100272483 B1 KR 100272483B1
Authority
KR
South Korea
Prior art keywords
lipid metabolism
cholesterol
compound
metabolism improving
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940006835A
Other languages
English (en)
Korean (ko)
Other versions
KR940021059A (ko
Inventor
가즈미 오가따
다까히로 사까우에
야스꼬 우메가끼
리에 나가오
Original Assignee
요시다 쇼지
센주 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼지, 센주 세이야꾸 가부시키가이샤 filed Critical 요시다 쇼지
Publication of KR940021059A publication Critical patent/KR940021059A/ko
Application granted granted Critical
Publication of KR100272483B1 publication Critical patent/KR100272483B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940006835A 1993-03-31 1994-03-31 지질 대사 개선제 Expired - Fee Related KR100272483B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7381493 1993-03-31
JP93-73814 1993-03-31

Publications (2)

Publication Number Publication Date
KR940021059A KR940021059A (ko) 1994-10-17
KR100272483B1 true KR100272483B1 (ko) 2000-11-15

Family

ID=13529009

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940006835A Expired - Fee Related KR100272483B1 (ko) 1993-03-31 1994-03-31 지질 대사 개선제

Country Status (8)

Country Link
US (1) US5474991A (enExample)
EP (1) EP0617963B1 (enExample)
KR (1) KR100272483B1 (enExample)
AT (1) ATE141508T1 (enExample)
CA (1) CA2116198A1 (enExample)
DE (1) DE69400382T2 (enExample)
ES (1) ES2091057T3 (enExample)
TW (1) TW252918B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866147A (en) * 1995-05-15 1999-02-02 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU1482102A (en) * 2000-11-14 2002-05-27 Tocovite Pty Ltd Complexes of phosphate derivatives
MXPA04000654A (es) * 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
WO2003092614A2 (en) * 2002-05-02 2003-11-13 Hickle Randall S Lipid removal from the body
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
DE602005025979D1 (de) 2004-03-03 2011-03-03 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
WO2006092025A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having lipid lowering properties
JP2008531602A (ja) * 2005-03-03 2008-08-14 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗癌特性を有する化合物
CA2611831C (en) * 2005-06-17 2014-09-16 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
JP2526059B2 (ja) * 1987-04-28 1996-08-21 千寿製薬株式会社 抗潰瘍剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
UA19385A1 (uk) * 1989-04-27 1997-12-25 Сендзю Фармасьютікал Ко. Лтд. Фофоліпідhі похідhі та композиція, яка має аhтиоксидаhтhу та іhгібуючу активhість щодо пероксидів ліпідів
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5231090A (en) * 1990-07-30 1993-07-27 University Of Miami Treatment for hypercholesterolemia
TW225992B (enExample) * 1992-07-17 1994-07-01 Senju Pharma Co

Also Published As

Publication number Publication date
US5474991A (en) 1995-12-12
CA2116198A1 (en) 1994-10-01
EP0617963B1 (en) 1996-08-21
ES2091057T3 (es) 1996-10-16
DE69400382T2 (de) 1996-12-19
TW252918B (enExample) 1995-08-01
KR940021059A (ko) 1994-10-17
DE69400382D1 (de) 1996-09-26
EP0617963A1 (en) 1994-10-05
ATE141508T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
KR100272483B1 (ko) 지질 대사 개선제
DE69814656T2 (de) Neue verbesserte formulierung zur behandlung der osteoporose
AU618796B2 (en) Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
EP0699440B1 (en) Use of a ascorbyl tocopheryl phosphate for the manufacture of a medicament for the treatment of pancreatitis
RU2268727C2 (ru) Лекарственное средство, обладающее защитным действием в отношении окислительно-токсических и прежде всего кардиотоксических соединений
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
FI88583B (fi) Foerfarande foer framstaellning av fettemulsioner, som innehaoller prostaglandin i2
US5489576A (en) Therapeutic agent for hemorrhoidal diseases
EP0674904B1 (en) Use of phosphoric acid diester compounds for suppressing hepatic metastases of tumors
Gimenez et al. Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid
EP0425956A2 (en) ACE inhibitors for use for stabilizing or causing regression of atherosclerosis in coronary arteries
US5885973A (en) Bone mass anabolic composition comprising olpadronate
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
EA002435B1 (ru) Способ снижения уровня липопротеина (а) в сыворотке или в плазме крови млекопитающих
EP1147773B1 (en) Medicinal compositions for treating osseous lesion in multiple myeloma
JP2003292453A (ja) 骨疾患治療用医薬複合剤
ITMI961010A1 (it) Composizioni farmaceutiche ciclosporina ed un veicolante compren- dente almeno un estere dell'acido a-glicerofosforico con colina
US5378692A (en) Method of lowering lipids
EP1704857B1 (en) Probucol spiroquinone or probucol diphenoquinone for use in the treatment of low hdl cholesterolemia
JP2714678B2 (ja) 虚血性臓器障害予防・治療剤
JP2876547B2 (ja) 抗クル病剤
US5478815A (en) Liver protectant tocophery-ascorbyl-phosphate
JPH0480007B2 (enExample)
JPH07233062A (ja) 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物
JPH07206684A (ja) 肝障害抑制剤

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030829

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030829

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000